Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study

Indian Journal of Pharmacology

Volumn 42, Issue 1, 2010, Pages 27-31

  Sangole, Nishant V ^a   Dadkar, Vaishali N ^a  

^a Padmashree Dr DY Patil Medical College   (India)

Author keywords

Adverse drug reaction; Angiotensin converting enzyme inhibitor; Angiotensin converting enzyme inhibitors; Antihypertensive; Dicarboxyl; Enalapril; Fosinopril; Lisinopril; Phosphonate; Ramipril

Indexed keywords

ENALAPRIL; FOSINOPRIL; LISINOPRIL; RAMIPRIL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COUGHING; DIARRHEA; DIZZINESS; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERKALEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NAUSEA; NEUTROPENIA; PATIENT MONITORING; PROSPECTIVE STUDY; RASH;

EID: 77951683522     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.62408     Document Type: Article

References (15)

1. Ondetti MA, Rubin B, Cushman DW. Design of specific inhibitors of Angiotensin converting enzyme: A new class of orally active hypertensive agents. Science 1977;196:441-6.
2. U.S Department of Health and Human Services. The Seventh Report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. August 28-29, 2004.
3. Uppsala monitoring centre. The use of the WHO-UMC system for standardized case causality assessment. Available from: http://www.who-umc.org/graphics/ 4409.pdf. [accessed on 2007 Nov 4]
4. Heart Outcomes Prevention Study Investigators (HOPE). Effect of ACE Inhibitor Ramipril on cardiovascular events in high risk patients. N Engl J Med 2000;342:143-5.
5. European Trial on Reduction of Cardiac events with Perindopril in stable Coronary Artery Disease (EUROPA) Investigators. Lancet 2003;362:782-8.
6. Arnolt MA, Damonte de Elia AR. Enalapril and cough. J Hypertension 1991;4:28A
7. Moyses C, Higgins TJ. Safety of long-term use of Lisinopril for congestive heart failure. Am J Cardiol 1992;70:91C-7C.
8. Williams B, Gosse P, Lowe L. The prospective, randomized investigation of safety and efficacy of telmisartan versus Ramipril using ambulatory blood pressure monitoring (PRISMA I). J Hypertens 2006;24:193-200
9. Bristol-Myers Squibb. Fosinopril prescribing information. Princeton (NJ). 1996
10. Anonymous. Cough caused by Angiotensin converting enzyme inhibitors. Drug Ther Bull 1994;32:28 and 55-56
11. Ferner RE, Simpson JM, Rawlins MD. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. BMJ 1987;294:1119-20
12. Morice AH, Lowry R, Brown MJ, Higenbottam T. Angiotensin converting enzyme and cough reflex. Lancet 1987;2:1116-8
13. Cooper WD, Sheldon D, Brown D, Kimber GR, Isitt VL, Currie WJ. Post marketing surveillance of Enalapril. 1987;37:346-9
14. Chu CS, Cheng KH, Lee KT, Lin TH, Lee ST, Su HM, et al. Tolerability of Ramipril 10 mg daily in high risk cardiovascular patients in Taiwan. Kaohsiung J Med Sci 2005;21:511-6
15. Schreiner M, Berendes B, Verho M, Langley A, Cairns V. Anithypertensive efficacy tolerance and safety of long term treatment with Ramipril. J Cardiovasc Pharmacol 1991;18:S137-40.